홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
SLNO
#1667
Soleno Therapeutics, Inc. Common Stock
39.0
7
+5.51%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+5.51%
월간 변동
-9.20%
6달 변화
-42.34%
년간 변동율
-13.27%
이전 종가
37.0
3
Open
39.0
7
Bid
Ask
Low
39.0
7
High
39.0
7
양
143
마켓
주식
헬스케어
SLNO
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
5.31 M
5.34 M
8.17 M
32.46 M
45.86 M
51.62 M
—
Valuation ratios
Enterprise value
—
—
3.29 M
1.06 B
1.97 B
2.32 B
13.6 B
Price to earnings ratio
—
—
-0.76
-16.08
-10.26
118.72
49.49
Price to sales ratio
—
—
—
—
—
12.74
—
Price to cash flow ratio
—
—
-0.88
-25.1
-26.14
51.83
-120.95
Price to book ratio
—
—
1.78
3.97
7.37
5.39
14.46
Enterprise value to EBITDA ratio
—
—
—
—
—
267.08
—
Profitability ratios
Return on assets %
0.38
0.87
0.91
0.22
0.53
0.04
0.1
Return on equity %
0.54
1.74
2.33
0.25
0.72
0.05
0.14
Return on invested capital %
275.44
1 091.59
904.19
1 615.72
3 509.39
26.23
—
Gross margin %
—
—
—
—
—
98.58
—
Operating margin %
—
—
—
—
—
4.94
—
EBITDA margin %
—
—
—
—
—
4.56
—
Net margin %
—
—
—
—
—
10.97
—
Liquidity ratios
Quick ratio
—
—
—
—
—
5.55
—
Current ratio
5.83
2.8
2.14
14.89
15.68
5.8
56.65
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
0.43
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
0.15
0.09
—
Long term debt to total equity ratio
—
—
—
—
0.2
0.11
—
Per share metrics
Operating cash flow per share
—
—
2.48
1.51
1.72
0.89
1.02
EBIT per share
—
—
—
—
—
0.13
—
EBITDA per share
—
—
—
—
—
0.17
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
1.74
10.29
7.25
5.83
26.88
Net current asset value per share
—
—
1.86
10.39
7.32
6.79
29.5
Tangible book value per share
—
—
-0.04
9.02
5.93
8.5
26.95
Working capital per share
—
—
0.99
9.69
6.85
5.62
26.96
Book value per share
—
—
1.23
9.55
6.1
8.59
27.39
뉴스
Soleno Therapeutics stock hits 52-week low at 36.01 USD
솔레노 테라퓨틱스, CFO에 제니퍼 풀크 임명
Soleno Therapeutics names Jennifer Fulk as CFO
Soleno Therapeutics earnings beat by $0.19, revenue topped estimates
솔레노 테라퓨틱스, 실적 발표 앞두고 시험대에 올라
Soleno Therapeutics faces earnings test as launch metrics scrutinized
Soleno Therapeutics stock hits 52-week low at 37.95 USD
Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome
Down 18.3% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround
FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug
솔레노 테라퓨틱스, 52주 신저가 기록
Soleno Therapeutics stock hits 52-week low at 39.42 USD